Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-09T03:29:34.143Z Has data issue: false hasContentIssue false
  • English
  • Français

High Prevalence of Reduced Chlorhexidine Susceptibility in Organisms Causing Central Line–Associated Bloodstream Infections

Published online by Cambridge University Press:  10 May 2016

Nuntra Suwantarat ,
Karen C. Carroll ,
Tsigereda Tekle ,
Tracy Ross ,
Lisa L. Maragakis ,
Sara E. Cosgrove  and
Aaron M. Milstone
Nuntra Suwantarat*
Affiliation:
Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Karen C. Carroll
Affiliation:
Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland Microbiology Laboratory, Johns Hopkins Hospital, Baltimore, Maryland
Tsigereda Tekle
Affiliation:
Microbiology Laboratory, Johns Hopkins Hospital, Baltimore, Maryland
Tracy Ross
Affiliation:
Microbiology Laboratory, Johns Hopkins Hospital, Baltimore, Maryland
Lisa L. Maragakis
Affiliation:
Division of Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, Maryland
Sara E. Cosgrove
Affiliation:
Division of Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, Maryland
Aaron M. Milstone
Affiliation:
Department of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, Maryland Division of Pediatric Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland
*
Division of Medical Microbiology, Johns Hopkins University School of Medicine, Meyer B1-193, 600 North Wolfe Street, Baltimore, MD 21287 (nsuwant1@jhmi.edu).
Get access Rights & Permissions [Opens in a new window]

Extract

In units that bathe patients daily with chlorhexidine gluconate (CHG), organisms causing central line–associated bloodstream infections (CLABSIs) were more likely to have reduced CHG susceptibility than organisms causing CLABSIs in units that do not bathe patients daily with CHG (86% vs 64%; P = .028). Surveillance is needed to detect reduced CHG susceptibility with widespread CHG use.

Infect Control Hosp Epidemiol 2014;35(9):1183-1186

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 9 , 01 September 2014 , pp. 1183 - 1186
Copyright
© 2014 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Milstone, AM, Elward, A, Song, X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013;381:1099–1106.Google Scholar
2. Climo, MW, Yokoe, DS, Warren, DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013;368:533–542.Google Scholar
3. Horner, C, Mawer, D, Wilcox, M. Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? J Antimicrob Chemother 2012;67:2547–2559.Google Scholar
4. Apisarnthanarak, A, Yang Hsu, L, Lim, TP, Mundy, LM. Increase in chlorhexidine minimal inhibitory concentration of Acinetobacter baumannii clinical isolates after implementation of advanced source control. Infect Control Hosp Epidemiol 2014;35:98–99.CrossRefGoogle ScholarPubMed
5. Higgins, CS, Murtough, SM, Williamson, E, et al. Resistance to antibiotics and biocides among non-fermenting gram-negative bacteria. Clin Microbiol Infect 2001;7:308–315.CrossRefGoogle ScholarPubMed
6. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 23rd Informational Supplement. Wayne, PA: CLSI, 2013. CLSI document M100-S23.Google Scholar
7. Alam, MM, Kobayashi, N, Uehara, N, et al. Analysis on distribution and genomic diversity of high-level antiseptic resistance genes qacA and qacB in human clinical isolates of Staphylococcus aureus. Microb Drug Resist 2003;9:109–121.CrossRefGoogle ScholarPubMed
8. Grare, M, Dibama, HM, Lafosse, S, et al. Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine. Clin Microbiol Infect 2010;16:432–438.Google Scholar
9. Kõljalg, S, Naaber, P, Mikelsaar, M. Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. J Hosp Infect 2002;51:106–113.CrossRefGoogle ScholarPubMed
10. Otter, JA, Patel, A, Cliff, PR, Halligan, EP, Tosas, O, Edgeworth, JD. Selection for qacA carriage in CC22, but not CC30, methicillin-resistant Staphylococcus aureus bloodstream infection isolates during a successful institutional infection control programme. J Antimicrob Chemother 2013;68:992–999.Google Scholar